Search Results for: ICAM3

29 interactions involving ICAM3 - intercellular adhesion molecule 3 found:

Sort by: Symbol Number of Pathways Number of Drugs Number of Diseases
Novel Symbol Description Pathways Hide Drugs Hide Diseases Hide
Novel C3 complement C3
  • Alternative complement activation
  • Activation of C3 and C5
  • Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
  • Peptide ligand-binding receptors
  • Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
  • G alpha (i) signalling events
  • Neutrophil degranulation
  • Post-translational protein phosphorylation
  • Purinergic signaling in leishmaniasis infection
  • Regulation of Complement cascade
  • Human immunoglobulin G
  • Zinc
  • S-Hydroxycysteine
  • Mirococept
  • Copper
  • Zinc acetate
  • Zinc chloride
  • Zinc sulfate, unspecified form
  • Pegcetacoplan
  • Macular degeneration, including: Age-related macular degeneration (ARMD); Patterned dystrophy of retinal pigment epithelium (PDREP); Retinal macular dystrophy 2 (MCDR2); X-linked atrophic macular degeneration (MDXLA)
  • Classic complement pathway component defects, including the following eight diseases: C1q alpha-chain deficiency; C1q beta-chain deficiency; C1q gamma-chain deficiency; C1r deficiency; C1s deficiency; C2 deficiency; C3 deficiency; C4 deficiency
Novel CALR calreticulin
  • ER-Phagosome pathway
  • Assembly of Viral Components at the Budding Site
  • Scavenging by Class A Receptors
  • Scavenging by Class A Receptors
  • Scavenging by Class F Receptors
  • Scavenging by Class F Receptors
  • ATF6 (ATF6-alpha) activates chaperone genes
  • Calnexin/calreticulin cycle
  • Antigen Presentation: Folding, assembly and peptide loading of class I MHC
  • Antihemophilic factor, human recombinant
  • Tenecteplase
  • Melatonin
  • Lanoteplase
  • Copper
  • Calcium citrate
  • Calcium Phosphate
  • Lonoctocog alfa
  • Moroctocog alfa
  • Calcium phosphate dihydrate
Novel EPOR erythropoietin receptor
  • Signaling by Erythropoietin
  • Signaling by Erythropoietin
  • Erythropoietin activates Phosphoinositide-3-kinase (PI3K)
  • Erythropoietin activates Phosphoinositide-3-kinase (PI3K)
  • Erythropoietin activates Phospholipase C gamma (PLCG)
  • Erythropoietin activates STAT5
  • Erythropoietin activates RAS
  • Erythropoietin activates RAS
  • Darbepoetin alfa
  • Erythropoietin
  • Dibromotyrosine
  • Peginesatide
  • Methoxy polyethylene glycol-epoetin beta
  • Congenital polycythemia; Familial erythrocytosis (ECYT)
Novel GCC2 GRIP and coiled-coil domain containing 2
  • Retrograde transport at the Trans-Golgi-Network
  • Signaling by ALK fusions and activated point mutants
Novel PRLR prolactin receptor
  • Prolactin receptor signaling
  • Prolactin receptor signaling
  • Growth hormone receptor signaling
  • Somatotropin
  • Lonapegsomatropin
Novel RFX2 regulatory factor X2
Novel RPL18 ribosomal protein L18
  • L13a-mediated translational silencing of Ceruloplasmin expression
  • Peptide chain elongation
  • SRP-dependent cotranslational protein targeting to membrane
  • SRP-dependent cotranslational protein targeting to membrane
  • Viral mRNA Translation
  • Selenocysteine synthesis
  • Major pathway of rRNA processing in the nucleolus and cytosol
  • Formation of a pool of free 40S subunits
  • GTP hydrolysis and joining of the 60S ribosomal subunit
  • Eukaryotic Translation Termination
  • Regulation of expression of SLITs and ROBOs
  • Response of EIF2AK4 (GCN2) to amino acid deficiency
  • Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)
  • Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
  • Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide
  • Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide
  • PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA
  • ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA
  • Artenimol
Novel TNFRSF1B TNF receptor superfamily member 1B
  • TNFR2 non-canonical NF-kB pathway
  • TNFs bind their physiological receptors
  • Interleukin-10 signaling
  • Interleukin-4 and Interleukin-13 signaling
  • Neutrophil degranulation
  • Tasonermin
  • Graft-versus-host disease
Novel USF2 upstream transcription factor 2, c-fos interacting
  • Estrogen-dependent gene expression
APP amyloid beta precursor protein
  • Platelet degranulation
  • ECM proteoglycans
  • Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
  • G alpha (q) signalling events
  • G alpha (i) signalling events
  • Lysosome Vesicle Biogenesis
  • Formyl peptide receptors bind formyl peptides and many other ligands
  • TAK1-dependent IKK and NF-kappa-B activation
  • The NLRP3 inflammasome
  • Advanced glycosylation endproduct receptor signaling
  • Advanced glycosylation endproduct receptor signaling
  • Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models
  • Post-translational protein phosphorylation
  • TRAF6 mediated NF-kB activation
  • Insertion of tail-anchored proteins into the endoplasmic reticulum membrane
  • Insertion of tail-anchored proteins into the endoplasmic reticulum membrane
  • Purinergic signaling in leishmaniasis infection
  • Amyloid fiber formation
  • Deferoxamine
  • Aluminium
  • Zinc
  • L-methionine (R)-S-oxide
  • Resveratrol
  • Tromethamine
  • Phenserine
  • Tetrathiomolybdate
  • CAD106
  • Mito-4509
  • Edonerpic
  • Dimercaprol
  • Copper
  • Florbetaben (18F)
  • Florbetapir (18F)
  • Flutemetamol (18F)
  • Gantenerumab
  • Aducanumab
  • Zinc acetate
  • Aluminium phosphate
  • Aluminum acetate
  • Zinc chloride
  • Zinc sulfate, unspecified form
  • Lecanemab
  • Alzheimer's disease (AD)
BRICD5 BRICHOS domain containing 5
CD209 CD209 molecule
  • CD209 (DC-SIGN) signaling
  • Butyrophilin (BTN) family interactions
  • RSV-host interactions
CLDN19 claudin 19
  • Tight junction interactions
CLDN4 claudin 4
  • Tight junction interactions
CLEC4M C-type lectin domain family 4 member M
  • RSV-host interactions
EDDM3B epididymal protein 3B
EZR ezrin
  • Netrin-1 signaling
  • Recycling pathway of L1
  • Recycling pathway of L1
  • Sensory processing of sound by inner hair cells of the cochlea
  • Sensory processing of sound by outer hair cells of the cochlea
ITGAD integrin subunit alpha D
  • Integrin cell surface interactions
ITGAL integrin subunit alpha L
  • Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
  • Cell surface interactions at the vascular wall
  • Integrin cell surface interactions
  • Neutrophil degranulation
  • RUNX3 Regulates Immune Response and Cell Migration
  • Efalizumab
  • Antithymocyte immunoglobulin (rabbit)
  • Lovastatin
  • Simvastatin
  • Rosuvastatin
  • 1-Acetyl-4-(4-{4-[(2-Ethoxyphenyl)Thio]-3-Nitrophenyl}Pyridin-2-Yl)Piperazine
  • LFA703
  • (S)-2-((S)-3-isobutyl-2,5-dioxo-4-quinolin-3-ylmethyl-[1,4]diazepan-1yl)-N-methyl-3-naphtalen-2-yl-propionamide
  • 7A-[(4-cyanophenyl)methyl]-6-(3,5-dichlorophenyl)-5-oxo-2,3,5,7A-tetrahydro-1H-pyrrolo[1,2-A]pyrrole-7-carbonitrile
  • 3-({4-[(1E)-3-morpholin-4-yl-3-oxoprop-1-en-1-yl]-2,3-bis(trifluoromethyl)phenyl}sulfanyl)aniline
  • Pitavastatin
  • Lifitegrast
ITGB2 integrin subunit beta 2
  • Toll Like Receptor 4 (TLR4) Cascade
  • Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
  • Cell surface interactions at the vascular wall
  • Integrin cell surface interactions
  • Interleukin-4 and Interleukin-13 signaling
  • Neutrophil degranulation
  • Leukocyte adhesion deficiency (LAD), including the following four diseases: Leukocyte adhesion deficiency (I); Leukocyte adhesion deficiency (II); Leukocyte adhesion deficiency (III); LAD with Rac2 deficiency

Page 1 out of 2 pages